A low-bacteria milk powder with a WPNI of at least 2 is suggested, obtainable by (a) providing a milk component; (b) optionally, separating the cream from the milk component; (c) subjecting the milk component from which the cream had been optionally separated to microfiltration, obtaining a low-bacteria permeate P1 and a bacteria-contaminated retentate R1; (d) mixing the permeate with a liquid lipid phase and a solid active agent phase; (e) optionally, subjecting the mixture obtained in step (d) to a temperature treatment; and (f) processing the mixture of step (d) or (e) that had optionally been temperature-treated, obtaining a dry powder.

A low-bacteria milk powder with a WPNI of at least 2 is suggested, obtainable by (a) providing a milk component; (b) optionally, separating the cream from the milk component; (c) subjecting the milk component from which the cream had been optionally separated to microfiltration, obtaining a low-bacteria permeate P1 and a bacteria-contaminated retentate R1; (d) mixing the permeate with a liquid lipid phase and a solid active agent phase; (e) optionally, subjecting the mixture obtained in step (d) to a temperature treatment; and (f) processing the mixture of step (d) or (e) that had optionally been temperature-treated, obtaining a dry powder.

A method for producing a milk or whey powder, involves providing milk or whey, thickening the milk or whey using a first evaporation process or second evaporation process, and drying the thickened milk or whey to provide a milk or whey powder. After the first or second evaporation process, the milk or whey is sterilized using a centrifugal bacteria-removing separator.

A method for the inactivation and inactivation testing of xenoantigens in foods of vegetable and animal origin, comprising the following steps: making up a solution with a food of vegetable or animal origin as a solvent and one or more phenolic compounds, polyphenolic compounds and derivatives thereof, comprising phenylpropanoids, as a solute, for the inactivation of at least part of the xenogeneic epitopes from said food, incubating samples of the food of vegetable or animal origin with the addition of an antibody aimed at a xenoantigen epitope that is present in the food, separating the resulting immune complex created owing to the bond between antigen and antibody, preparing a well plate for the E.L.I.S.A. test with coating with xenoantigen epitope, adding, in the wells, supernatant taken from the samples, the supernatant containing the part of antibody that has not bonded with epitopes, a column of wells being adapted to define a reference value that corresponds to the maximum signal between antibody and epitopes, completing the plate with a secondary antibody conjugated with an enzyme, or other molecule, adapted to chromatically highlight any presence of anti-xenoantigen antibody, reading the plate, determining the presence of anti-xenoantigen antibody that has remained free in the solutions of the samples, comparing the absorbance values detected in the reference column with the values in the other columns of samples of the plate.

A method for the inactivation and inactivation testing of xenoantigens in foods of vegetable and animal origin, comprising the following steps: making up a solution with a food of vegetable or animal origin as a solvent and one or more phenolic compounds, polyphenolic compounds and derivatives thereof, comprising phenylpropanoids, as a solute, for the inactivation of at least part of the xenogeneic epitopes from said food, incubating samples of the food of vegetable or animal origin with the addition of an antibody aimed at a xenoantigen epitope that is present in the food, separating the resulting immune complex created owing to the bond between antigen and antibody, preparing a well plate for the E.L.I.S.A. test with coating with xenoantigen epitope, adding, in the wells, supernatant taken from the samples, the supernatant containing the part of antibody that has not bonded with epitopes, a column of wells being adapted to define a reference value that corresponds to the maximum signal between antibody and epitopes, completing the plate with a secondary antibody conjugated with an enzyme, or other molecule, adapted to chromatically highlight any presence of anti-xenoantigen antibody, reading the plate, determining the presence of anti-xenoantigen antibody that has remained free in the solutions of the samples, comparing the absorbance values detected in the reference column with the values in the other columns of samples of the plate.

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation comprising at least one or several of: a plurality of isolated, or substantially purified bacteriophages or prophages, or bacteriophage subunits, a milk, a milk product, milk lipid, milk fat globule (MFG) macromolecule, a milk mucin, a milk glycolipid, a milk free glycan, a milk mucin-like glycoprotein, a milk protein, a milk sugar or lactose, a milk fat or butterfat, a milk vitamin. In alternative embodiment, provided are compositions and methods for treating, preventing or ameliorating an infection, for example, an infection in the gastrointestinal tract, or bowel.

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation comprising at least one or several of: a plurality of isolated, or substantially purified bacteriophages or prophages, or bacteriophage subunits, a milk, a milk product, milk lipid, milk fat globule (MFG) macromolecule, a milk mucin, a milk glycolipid, a milk free glycan, a milk mucin-like glycoprotein, a milk protein, a milk sugar or lactose, a milk fat or butterfat, a milk vitamin. In alternative embodiment, provided are compositions and methods for treating, preventing or ameliorating an infection, for example, an infection in the gastrointestinal tract, or bowel.

Methods for extracting protein from expired or spoiled milk is disclosed. In at least one embodiment, the method includes the steps of acid hydrolysis, first filtration, fine filtration, activation, salting out, degreasing, drying and packaging. Through the combined process of “protein activation” and “self-assembly salting out,” these methods enable the reuse and upcycling of expired and spoiled milk.

Methods for extracting protein from expired or spoiled milk is disclosed. In at least one embodiment, the method includes the steps of acid hydrolysis, first filtration, fine filtration, activation, salting out, degreasing, drying and packaging. Through the combined process of “protein activation” and “self-assembly salting out,” these methods enable the reuse and upcycling of expired and spoiled milk.

A low-bacteria milk powder with a WPNI of at least 2 is suggested, obtainable by (a) providing a milk component; (b) optionally, separating the cream from the milk component; (c) subjecting the milk component from which the cream had been optionally separated to microfiltration, obtaining a low-bacteria permeate P1 and a bacteria-contaminated retentate R1; (d) mixing the permeate with a liquid lipid phase and a solid active agent phase; (e) optionally, subjecting the mixture obtained in step (d) to a temperature treatment; and (f) processing the mixture of step (d) or (e) that had optionally been temperature-treated, obtaining a dry powder.